BPG is committed to discovery and dissemination of knowledge
Home / Archive / Volume 17, Issue 1
  • This Article
Peer-Review Report of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Journal Information of This Article
Publication Name
World Journal of Gastrointestinal Pharmacology and Therapeutics
ISSN
2150-5349
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Editorial
©The Author(s) 2026.
World J Gastrointest Pharmacol Ther. Mar 5, 2026; 17(1): 112327
Published online Mar 5, 2026. doi: 10.4292/wjgpt.v17.i1.112327
Figure 2
Full Size Figure Download Figure
Figure 2 Mechanism of action of elobixibat (ileal bile acid transporter inhibitor) and effect of increased bile acid pool on colonocytes. ASBT: Apical sodium-dependent bile acid transporter; CFTR: Cystic fibrosis transmembrane conductance regulator; cAMP: Cyclic adenosine monophosphate; OSTα/β: Organic solute transporter alpha/beta; TGR5: Takeda G-protein coupled receptor.
Write to the Help Desk
Copyright © 1993-2026 Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA. All rights reserved, including rights relating to text and data mining, AI training, and similar technologies. For open-access content, the applicable copyright and licensing terms govern.